| 名称 | Reslizumab |
| 描述 | Reslizumab (Sch 55700) is a humanized immunoglobulin G (IgG)4 κ monoclonal antibody that binds to human interleukin 5, thereby decreasing eosinophil production and survival.Reslizumab improves lung function, induces a decrease in eosinophil production and maturation, and may be used in the study of asthma. |
| 体外活性 | Reslizumab与人IL-5的结合亲和力很高,在Biacore表面等离子共振,KD=109 pM和动力学排阻实验中的,KD=4.3 pM。[1]
Reslizumab 与 hIL-5 的亲和力很高(Kd = 20 pM),能抑制 hIL-5 与 Ba/F3 细胞的结合(IC50 = 0.5 nM),并能阻断 IL-5 介导的人类红细胞白血病 TF-1 细胞的增殖。[2] |
| 体内活性 | 腹腔或肌肉注射0-10 mg/kg Reslizumab 以剂量依赖的方式抑制过敏性小鼠的肺嗜酸性粒细胞增多。
静脉注射 30 mg/kg Reslizumab 可抑制过敏性豚鼠的过敏性支气管收缩,但不能抑制组胺诱导的支气管收缩。静脉注射 0.1-1 mg/kg Reslizumab 可阻断气管注射 hIL-5 引起的豚鼠肺嗜酸性粒细胞和中性粒细胞增多。
静脉注射 0.3 mg/kg Reslizumab 可在过敏性绒猴体内阻断抗原挑战引起的肺嗜酸性粒细胞增多长达 6 个月。 [2] |
| 存储条件 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 关键字 | Reslizumab | ILReceptor | IL-5-dependent cell proliferation | IL-5 | IL Receptor |
| 相关产品 | Ethyl palmitate | Sodium Thiocyanate | Amlexanox | Diallyl disulfide | Inosine pranobex | Dexamethasone acetate | Dexamethasone | 1,8-Cineole | L-Arginine | Theophylline monohydrate | Balsalazide disodium dihydrate | Disulfiram |